Understanding and Preventing HIV in High-Risk Communities

Leveraging Extensive Social Determinants Data and Spatial Data Science to Reduce HIV Incidence across the United States Ending the HIV Epidemic Counties

['FUNDING_R01'] · YALE UNIVERSITY · NIH-11176844

This project uses detailed information about communities to help reduce new HIV infections and improve access to prevention services in areas most affected by HIV.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorYALE UNIVERSITY (nih funded)
Locations1 site (NEW HAVEN, UNITED STATES)
Trial IDNIH-11176844 on ClinicalTrials.gov

What this research studies

New HIV diagnoses and the use of preventative medicines like PrEP vary widely across different parts of the country. This project focuses on 57 specific areas in the U.S. that have the highest rates of HIV. We are using advanced data science to pinpoint exactly where new HIV cases are appearing and where there might be a shortage of PrEP providers. Our goal is to understand how factors like transportation, community mental health, social connections, and local religious institutions affect HIV prevention. By identifying these key factors, we can help ensure that PrEP services are placed in the most effective locations to reach people who need them.

Who could benefit from this research

Good fit: This project is not recruiting individual patients but aims to benefit communities and individuals living in or at risk of HIV in the 57 targeted high-incidence areas across the United States.

Not a fit: Patients living outside the specific high-HIV-incidence counties and states targeted by the Ending the HIV Epidemic initiative may not directly benefit from the findings of this particular grant.

Why it matters

Potential benefit: If successful, this work could lead to more effective strategies for distributing HIV prevention resources, ultimately reducing new infections and improving community health.

How similar studies have performed: While the use of spatial data science and cyberinfrastructure for this specific combination of contextual factors in HIV prevention is novel, similar data-driven approaches have shown promise in public health planning.

Where this research is happening

NEW HAVEN, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.